GlassScriptPhysician profile
Lisa M Bean
NPI 1760782817
$5,374.71
in general payments reported to CMS, 2019-2025
11 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.91 · 2020: $163 · 2022: $119 · 2023: $24.41 · 2024: $4,904 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Food and Beverage: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Food and Beverage | $562.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,808.76 | 2024 | |
| Abbvie INC. | $118.83 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $118.06 | 2020 | |
| Hologic Sales and Service, LLC | $80.18 | 2024-2025 | Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $63.68 | 2019-2025 | |
| Aspira Women'S Health INC | $48.91 | 2023-2024 | Ova1 |
| Shield Therapeutics INC | $43.65 | 2025 | |
| Organon LLC | $32.88 | 2024 | |
| Astellas Pharma US INC | $31.03 | 2025 | Veozah |
| Amarin Pharma, INC. | $14.69 | 2019 | |
| Medtronic Vascular, INC. | $14.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Bean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.